Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years.

Aim: To portray liver disease and project outcomes in carriers of hepatitis C virus (HCV) in the general population.

Methods: Liver disease was evaluated in 1019 individuals who were found with HCV infection at blood donation, and they were followed for 5-10 years with or without receiving interferon (IFN).

Results: At baseline, chronic hepatitis was detected in 529 (51.